Adjusting the price of rituximab injection produced by Shanghai Fuhong Hanlin
Shanghai Fuhong Hanlin Biopharmaceutical Co., Ltd. submitted an application for adjusting the purchase price of rituximab injection (100mg/10ml). After research, it agreed to the application for adjusting the purchase price of rituximab. The winning price of monoclonal antibody injection (100mg/10ml) was adjusted from 1640.00 yuan per bottle to 1398.00 yuan per bottle.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-07-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
25 million with one injection?! The record for 'the world's most expensive drug' is still controversial...
-
Tonghua Dongbao's 'Liraglutide Injection' Declared for Listing
-
Pfizer GDF15 Monoclonal Antibody Ponsegromab Injection Applied for Clinical Application
-
Approval of The Clinical Trial Application of WuXi Giant Norricy Orenza Injection For r/r B-ALL
-
Renfu Pharmaceutical's Class 1 New Drug Propofol Disodium Phosphate for Injection Approved
-
A panoramic analysis of traditional Chinese medicine injection
-
Taiji Group stirred up 1.5 bn injections and Pfizer and Hawson met their rivals.
Recommend Reading
-
Insufficient Support, n-Butanol Market Continues to Decline in China
-
China's Propylene Oxide Market Prices Show a High-Level Correction (2.2-2.6)
-
This Week's Epichlorohydrin Market Prices Decline in China (2.2-2.6)
-
Ample Supply, Toluene Market Declines in China
-
Multiple Negative Factors Weigh on Butadiene Market, Leading to a Slight Decline